21 unchanged sentences
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE .
−Removed: The information required by this item will be set forth in the sections entitled “Information Regarding the Board of Directors and Corporate Governance,” “Information Regarding Executive Officers” and “Section 16(a) Beneficial Ownership Reporting Compliance” in our Definitive Proxy Statement for our 2023 Annual Meeting of Stockholders (our “2023 Proxy Statement”), to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022, and is incorporated herein by reference.
+Added: The information required by this item will be set forth in the sections entitled “Information Regarding the Board of Directors and Corporate Governance,” “Information Regarding Executive Officers” and “Delinquent Section 16(a) Reports” in our Definitive Proxy Statement for our 2024 Annual Meeting of Stockholders (our “2024 Proxy Statement”), to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2023, and is incorporated herein by reference.
EXECUTIVE COMPENSATION.
26 unchanged sentences
Capricor, Inc.
−Removed: 2006 Stock Option Plan (incorporated by reference to Exhibit 4.4 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: Capricor, Inc.
2012 Restated Equity Incentive Plan (incorporated by reference to Exhibit 4.5 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: Capricor, Inc.
−Removed: 2012 Non-Employee Director Stock Option Plan (incorporated by reference to Exhibit 4.6 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
First Amendment to Capricor, Inc.
−Removed: 2006 Stock Option Plan (incorporated by reference to Exhibit 4.11 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: First Amendment to Capricor, Inc.
2012 Restated Equity Incentive Plan (incorporated by reference to Exhibit 4.12 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: First Amendment to Capricor, Inc.
−Removed: 2012 Non-Employee Director Stock Option Plan (incorporated by reference to Exhibit 4.13 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: Form of Incentive Stock Option Agreement for the Capricor, Inc.
−Removed: 2006 Stock Option Plan (incorporated by reference to Exhibit 4.7 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: Form of Non-Qualified Stock Option Agreement for the Capricor, Inc.
−Removed: 2006 Stock Option Plan (incorporated by reference to Exhibit 4.8 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
Form of Stock Option Agreement for the Capricor, Inc.
2012 Restated Equity Incentive Plan (incorporated by reference to Exhibit 4.9 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
−Removed: Form of Stock Option Agreement for the Capricor, Inc.
−Removed: 2012 Non-Employee Director Stock Option Plan (incorporated by reference to Exhibit 4.10 to the Company’s Registration Statement on Form S-8, filed with the Commission on March 4, 2014).
Exclusive License Agreement, dated June 21, 2006, between Capricor, Inc.
74 unchanged sentences
and Cedars-Sinai Medical Center (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on November 11, 2020).+
−Removed: Exclusive License Agreement, dated as of April 28, 2021, by and between Capricor, Inc.
−Removed: and Johns Hopkins University (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q, filed with the Commission on August 13, 2021).+
Capricor Therapeutics, Inc.
9 unchanged sentences
and Nippon Shinyaku Co.
+Added: (incorporated by reference to Exhibit 10.55 to the Company’s Annual Report on Form 10-K, filed with the Commission on March 17, 2023).
List of Subsidiaries.
5 unchanged sentences
Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
+Added: Capricor Therapeutics, Inc.
+Added: Policy on Recoupment of Incentive Compensation.
The following financial information from Capricor Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2023 formatted in Inline eXtensible Business Reporting Language (iXBRL):
24 unchanged sentences
March 8, 2024
−Removed: (Principal Financial and Accounting Officer)
+Added: (Principal Financial and Principal Accounting Officer)
/s/ Frank Litvack, M.D.
9 unchanged sentences
Karimah Es Sabar
+Added: /s/ Paul Auwaerter
March 8, 2024
+Added: Paul Auwaerter
+Added: /s/ Michael Kelliher
+Added: March 8, 2024
+Added: Michael Kelliher
+Added: /s/ Philip Gotwals
+Added: March 8, 2024
+Added: Philip Gotwals
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.